African Americans
Gene Therapy for Sickle Cell Disease Sparks Dilemma Among African Americans
Research at Georgia State University highlights the challenge of gene therapy uptake for treating sickle cell disease in the African American community. Although the US FDA-approved therapies, Casgevy and Lyfgenia, show promise in treating the disease, the African American community is facing a dilemma due to low uptake of these